Home BancShares Inc (HOMB)
Official siteFINANCIAL SERVICES • BANKS - REGIONAL • NYSE
Market Cap: $5.96B
Last updated: Nov 17, 2026 at 11:06 AM ET
Home BancShares Inc (HOMB) Stock Forecast
Analysts expect Home BancShares (HOMB) to earn $2.53 per share in the fiscal year ending Dec 31, 2026, on revenue of $1.15B. Of 10 analysts, 4 rate the stock Buy or Strong Buy, 6 Hold and 0 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 6 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 10 ratings average 2.50, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 40% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 10.0% |
| Buy | 3 | 30.0% |
| Hold | 6 | 60.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Hold
- Total analysts
- 10
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 2.8% and revenue estimates rise 3.5%.
- Fiscal year ending Dec 31, 2026
- $2.53
- EPS consensus, revenue $1.15B
- Fiscal year ending Dec 31, 2027
- $2.60
- EPS consensus, revenue $1.19B
- Next report
- Jan 12, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $2.53 | $2.50 to $2.55 | 10 | $1.15B | $1.13B to $1.15B | 9 |
| Dec 31, 2027 | $2.60 | $2.54 to $2.65 | 10 | $1.19B | $1.16B to $1.21B | 9 |
Quarterly Estimates
The EPS consensus falls from $0.66 for the quarter ending Dec 31, 2026 to $0.62 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.66 | $0.60 to $0.70 | 11 | $300.24M | $284.82M to $313.64M | 10 |
| Mar 31, 2027 | $0.62 | $0.60 to $0.64 | 9 | $288.42M | $280.79M to $292.00M | 8 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 10 upward and 9 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 6 | 1 |
| Fiscal year ending Dec 31, 2027 | 3 | 3 |
| Quarter ending Mar 31, 2027 | 1 | 5 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 0.8% from $2.51.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $2.53 | $2.53 | $2.52 | $2.51 | $2.51 | +0.8% |
| Fiscal year ending Dec 31, 2027 | $2.60 | $2.60 | $2.60 | $2.60 | $2.60 | -0.1% |
| Quarter ending Mar 31, 2027 | $0.62 | $0.62 | $0.63 | $0.62 | $0.62 | +0.1% |
Frequently Asked Questions About HOMB
What is the HOMB stock forecast?
Consensus analyst estimates put Home BancShares's EPS at $2.53 for the fiscal year ending Dec 31, 2026, on revenue of $1.15B. The consensus rating from 10 analysts is Hold.
How do analysts rate HOMB stock?
Of 10 analysts covering Home BancShares, 1 rates it Strong Buy, 3 Buy, 6 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from HOMB next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $2.53, with estimates from $2.50 to $2.55 from 10 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $2.60, with estimates from $2.54 to $2.65 from 10 analysts.
What revenue do analysts expect from Home BancShares next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $1.15B, with estimates from $1.13B to $1.15B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $1.19B, with estimates from $1.16B to $1.21B.
How many analysts cover HOMB?
10 analysts rate Home BancShares stock, and 10 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
HOMB pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors